Legacy Wealth Asset Management LLC Has $753,000 Holdings in STERIS plc (NYSE:STE)

Legacy Wealth Asset Management LLC lessened its holdings in STERIS plc (NYSE:STE) by 3.2% during the fourth quarter, HoldingsChannel reports. The fund owned 3,662 shares of the medical equipment provider’s stock after selling 121 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in STERIS were worth $753,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in STE. Ashton Thomas Securities LLC purchased a new stake in STERIS in the 3rd quarter valued at about $25,000. Central Pacific Bank Trust Division purchased a new stake in STERIS in the 3rd quarter valued at about $28,000. Brown Brothers Harriman & Co. increased its stake in STERIS by 154.7% in the 2nd quarter. Brown Brothers Harriman & Co. now owns 191 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 116 shares during the last quarter. Quarry LP purchased a new stake in STERIS in the 3rd quarter valued at about $67,000. Finally, Asset Dedication LLC increased its stake in STERIS by 54.8% in the 3rd quarter. Asset Dedication LLC now owns 291 shares of the medical equipment provider’s stock valued at $71,000 after buying an additional 103 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Down 0.3 %

STE opened at $209.50 on Friday. The company has a 50 day moving average of $212.04 and a 200 day moving average of $224.72. The company has a market cap of $20.68 billion, a PE ratio of 47.83 and a beta of 0.84. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping the consensus estimate of $2.12 by $0.02. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.33 billion. STERIS had a net margin of 8.02% and a return on equity of 13.78%. STERIS’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period last year, the firm earned $2.03 EPS. On average, sell-side analysts expect that STERIS plc will post 9.1 EPS for the current year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, December 19th. Shareholders of record on Tuesday, November 19th were issued a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.09%. The ex-dividend date was Tuesday, November 19th. STERIS’s payout ratio is 52.05%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on STE. Piper Sandler raised shares of STERIS from a “neutral” rating to an “overweight” rating and increased their target price for the company from $230.00 to $260.00 in a research report on Thursday, October 24th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. JMP Securities reissued a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Monday, November 18th. Stephens reissued an “overweight” rating and set a $260.00 target price on shares of STERIS in a research report on Thursday, November 7th. Finally, StockNews.com downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $262.50.

Insider Buying and Selling at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of the firm’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $217.32, for a total value of $365,532.24. Following the completion of the transaction, the senior vice president now directly owns 11,372 shares of the company’s stock, valued at $2,471,363.04. This trade represents a 12.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 1.14% of the company’s stock.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.